Narendran P - Search Results

1

Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.

Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Crabtree TSJ, et al. Among authors: narendran p. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. Diabetes Care. 2023. PMID: 37566697 Free PMC article.

2

Lack of agreement between arterial and central venous blood glucose measurement in critically ill children.

Nayak PP, Morris K, Lang H, Laker S, Stickley J, Davies P, Barrett T, Gao F, Gough S, Narendran P. Nayak PP, et al. Among authors: narendran p. Intensive Care Med. 2009 Apr;35(4):762-3. doi: 10.1007/s00134-008-1282-6. Epub 2008 Sep 16. Intensive Care Med. 2009. PMID: 18797845 No abstract available.

3

Hypoglycemia in non-diabetic in-patients: clinical or criminal?

Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, Coleman JJ, Ferner RE. Nirantharakumar K, et al. Among authors: narendran p. PLoS One. 2012;7(7):e40384. doi: 10.1371/journal.pone.0040384. Epub 2012 Jul 2. PLoS One. 2012. PMID: 22768352 Free PMC article.

4

Insulin prescribing is unsafe: education results in a significant but insufficient improvement.

Clarke NR, Narendran P. Clarke NR, et al. Among authors: narendran p. Diabet Med. 2005 Dec;22(12):1779-80. doi: 10.1111/j.1464-5491.2005.01744.x. Diabet Med. 2005. PMID: 16401331 No abstract available.

5

IGF-secreting tumour treated with a combination of growth hormone and glucocorticoids.

Narendran P, Younger T, Au-Yeung A, Bingley PJ. Narendran P, et al. Clin Endocrinol (Oxf). 2006 May;64(5):596-7. doi: 10.1111/j.1365-2265.2006.02482.x. Clin Endocrinol (Oxf). 2006. PMID: 16649982 No abstract available.

6

Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes.

Narendran P, Elsegood K, Leech NJ, Macindoe WM, Boons GJ, Dayan CM. Narendran P, et al. Immunology. 2004 Apr;111(4):422-9. doi: 10.1111/j.1365-2567.2004.01825.x. Immunology. 2004. PMID: 15056379 Free PMC article.

7

Length of hospital stay is shorter in black and ethnic minority patients with diabetes.

Kimani KN, Potluri R, Natalwala A, Ghosh S, Heun R, Narendran P. Kimani KN, et al. Among authors: narendran p. Diabet Med. 2012 Jun;29(6):830-1. doi: 10.1111/j.1464-5491.2011.03512.x. Diabet Med. 2012. PMID: 22050447 No abstract available.

8

Lymphotoxin signals from positively selected thymocytes regulate the terminal differentiation of medullary thymic epithelial cells.

White AJ, Nakamura K, Jenkinson WE, Saini M, Sinclair C, Seddon B, Narendran P, Pfeffer K, Nitta T, Takahama Y, Caamano JH, Lane PJ, Jenkinson EJ, Anderson G. White AJ, et al. Among authors: narendran p. J Immunol. 2010 Oct 15;185(8):4769-76. doi: 10.4049/jimmunol.1002151. Epub 2010 Sep 22. J Immunol. 2010. PMID: 20861360 Free PMC article.

9

Proinsulin-a pathogenic autoantigen in type 1 diabetes.

Narendran P, Mannering SI, Harrison LC. Narendran P, et al. Autoimmun Rev. 2003 Jun;2(4):204-10. doi: 10.1016/s1568-9972(03)00009-0. Autoimmun Rev. 2003. PMID: 12848947 Review.

10

Insulin resistance is a risk factor for progression to type 1 diabetes.

Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Fourlanos S, et al. Among authors: narendran p. Diabetologia. 2004 Oct;47(10):1661-7. doi: 10.1007/s00125-004-1507-3. Epub 2004 Oct 6. Diabetologia. 2004. PMID: 15480539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters